Evidence map›Paper›PMID 29321309›Full record

ArticleJournal of virology2018

Specific Mutations in the PB2 Protein of Influenza A Virus Compensate for the Lack of Efficient Interferon Antagonism of the NS1 Protein of Bat Influenza A-Like Viruses.

Teresa Aydillo, Juan Ayllon, Amzie Pavlisin, Carles Martinez-Romero, Shashank Tripathi, Ignacio Mena, Andrés Moreira-Soto, Amanda Vicente-Santos, Eugenia Corrales-Aguilar, Martin Schwemmle and 1 more

Open access · bronzeAbstract read
In one paragraph

Article in Journal of virology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 14 citations in OpenAlex.

  1. Cu-MOF-NHMikrochimica acta · 2026
    Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 3 countries.

Teresa AydilloDepartment of Microbiology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Juan AyllonDepartment of Microbiology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Amzie PavlisinDepartment of Microbiology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Carles Martinez-RomeroDepartment of Microbiology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Shashank TripathiDepartment of Microbiology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Ignacio MenaDepartment of Microbiology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Andrés Moreira-SotoVirology-CIET, Faculty of Microbiology, University of Costa Rica, San José, Costa Rica.
Amanda Vicente-SantosVirology-CIET, Faculty of Microbiology, University of Costa Rica, San José, Costa Rica.
Eugenia Corrales-AguilarVirology-CIET, Faculty of Microbiology, University of Costa Rica, San José, Costa Rica.
Martin SchwemmleInstitute of Virology, Medical Center, University of Freiburg, Freiburg, Germany.
Adolfo García-SastreDepartment of Microbiology, Icahn School of Medicine at Mount Sinai, New York, New York, USA Adolfo.Garcia-Sastre@mssm.edu.
Icahn School of Medicine at Mount Sinai · USUniversidad de Costa Rica · CRUniversity of Freiburg · DE

Funding

NIAID NIH HHS HHSN272201400008C
6 · The paper itself

Abstract

Recently, two new influenza A-like viruses have been discovered in bats, A/little yellow-shouldered bat/Guatemala/060/2010 (HL17NL10) and A/flat-faced bat/Peru/033/2010 (HL18NL11). The hemagglutinin (HA)-like (HL) and neuraminidase (NA)-like (NL) proteins of these viruses lack hemagglutination and neuraminidase activities, despite their sequence and structural homologies with the HA and NA proteins of conventional influenza A viruses. We have now investigated whether the NS1 proteins of the HL17NL10 and HL18NL11 viruses can functionally replace the NS1 protein of a conventional influenza A virus. For this purpose, we generated recombinant influenza A/Puerto Rico/8/1934 (PR8) H1N1 viruses containing the NS1 protein of the PR8 wild-type, HL17NL10, and HL18NL11 viruses. These viruses (r/NS1PR8, r/NS1HL17, and r/NS1HL18, respectively) were tested for replication in bat and nonbat mammalian cells and in mice. Our results demonstrate that the r/NS1HL17 and r/NS1HL18 viruses are attenuated

Indexed as

Influenza A virusInterferonsMutationViral Nonstructural ProteinsViral ProteinsA549 CellsHEK293 CellsHumansINS1 protein, influenza virusInterferonsPB2 protein, influenza virusViral Nonstructural ProteinsViral Proteinsbatinfluenza virusesinterferonsNS1 protein

Identifiers

PMID29321309
PMCPMC5972909
OpenAlexW2783357598

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.